Keywords: GLP-1 receptor agonists, psoriasis, wound healing, hidradenitis suppurativa, cutaneous adverse effects Introduction Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced in the intestinal epithelial endocrine L-cells following meal intake
[26] Many women experience weight changes during the menopausal transition, which can be attributed to hormonal changes, aging, and lifestyle factors
Furthermore, repeated high-dose injections may alter the balance of antioxidants in the body, potentially triggering oxidative stress rather than reducing it
Dehydration leads to a rapid decline in strength and cognitive focus
Aggregation occurs when individual tirzepatide molecules clump together, transitioning from their normal alpha-helix structure to beta-sheet formations